Cigna Group CI revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Cigna Group reported revenue across 4 products and services; the largest, Product, was $217B, 86.3% of the filed sum (+16.9% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product$217B86.3%+16.9% yoy
- Service$16.9B6.7%+14.4% yoy
- Service Fees And Other Revenues$16.9B6.7%+14.4% yoy
- Service Other$696M0.3%+19.2% yoy
Members sum to $251B against $275B consolidated (residual $23.7B) - eliminations or corporate lines the filer did not tag on this axis.
- Product$57.2B86.3%+6.6% yoy
- Service$4.37B6.6%+5.5% yoy
- Service Fees And Other Revenues$4.37B6.6%+5.5% yoy
- Service Other$315M0.5%+176.3% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.